Everett Rand Sutherland - 30 Jun 2024 Form 4 Insider Report for Krystal Biotech, Inc. (KRYS)

Role
Director
Signature
/s/ Krish Krishnan, as attorney-in-fact for Everett Rand Sutherland
Issuer symbol
KRYS
Transactions as of
30 Jun 2024
Net transactions value
$0
Form type
4
Filing time
01 Jul 2024, 19:24:06 UTC
Previous filing
03 Aug 2023
Next filing
10 Oct 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRYS Stock Option (Right to Buy) Award $0 +5,000 $0.000000 5,000 30 Jun 2024 Common Stock 5,000 $183.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were awarded on June 30, 2024 and vest in equal monthly tranches over a one-year period.